CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia

Leuk Lymphoma. 2022 Apr;63(4):996-1000. doi: 10.1080/10428194.2021.2005042. Epub 2021 Nov 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • ADP-ribosyl Cyclase 1
  • Adult
  • Antigens, CD34
  • Flow Cytometry
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Neoplastic Stem Cells
  • Prognosis
  • Stem Cells

Substances

  • Antigens, CD34
  • ADP-ribosyl Cyclase 1